Ballentine Partners LLC lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 16.2% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 11,474 shares of the healthcare conglomerate’s stock after purchasing an additional 1,601 shares during the quarter. Ballentine Partners LLC’s holdings in UnitedHealth Group were worth $2,178,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Patriot Financial Group Insurance Agency LLC lifted its stake in shares of UnitedHealth Group by 1,722.9% in the 1st quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after acquiring an additional 603 shares during the last quarter. Kings Point Capital Management lifted its stake in shares of UnitedHealth Group by 27.9% in the 1st quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after acquiring an additional 150 shares during the last quarter. Founders Capital Management bought a new stake in shares of UnitedHealth Group in the 1st quarter valued at about $135,000. Parkside Financial Bank & Trust lifted its stake in shares of UnitedHealth Group by 1.4% in the 1st quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after acquiring an additional 12 shares during the last quarter. Finally, Hanson McClain Inc. lifted its stake in shares of UnitedHealth Group by 1.7% in the 1st quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock valued at $147,000 after acquiring an additional 15 shares during the last quarter. Hedge funds and other institutional investors own 86.09% of the company’s stock.
Shares of UnitedHealth Group Incorporated (NYSE UNH) opened at 212.60 on Friday. The stock has a market cap of $210.26 billion, a P/E ratio of 24.14 and a beta of 0.63. UnitedHealth Group Incorporated has a 1-year low of $136.22 and a 1-year high of $212.77. The company has a 50 day moving average price of $198.15 and a 200 day moving average price of $186.99.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. The company had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. UnitedHealth Group’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.17 earnings per share. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post $9.99 EPS for the current year.
In other UnitedHealth Group news, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction on Monday, August 21st. The shares were sold at an average price of $191.71, for a total value of $2,875,650.00. Following the transaction, the director now directly owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Thomas E. Roos sold 975 shares of UnitedHealth Group stock in a transaction on Thursday, October 19th. The stock was sold at an average price of $205.47, for a total transaction of $200,333.25. Following the completion of the transaction, the insider now directly owns 24,630 shares in the company, valued at $5,060,726.10. The disclosure for this sale can be found here. Insiders sold 77,149 shares of company stock valued at $15,182,242 in the last three months. 0.89% of the stock is currently owned by insiders.
A number of equities research analysts have recently weighed in on UNH shares. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, October 10th. ValuEngine lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 5th. Sanford C. Bernstein reissued an “outperform” rating and issued a $190.00 target price on shares of UnitedHealth Group in a research note on Monday, July 10th. Deutsche Bank AG boosted their target price on UnitedHealth Group from $187.00 to $197.00 and gave the company a “buy” rating in a research note on Thursday, July 13th. Finally, Oppenheimer Holdings, Inc. reissued an “outperform” rating and issued a $205.00 target price (up previously from $203.00) on shares of UnitedHealth Group in a research note on Friday, July 21st. Three investment analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company. UnitedHealth Group has an average rating of “Buy” and a consensus price target of $215.27.
TRADEMARK VIOLATION NOTICE: “Ballentine Partners LLC Has $2.18 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The correct version of this story can be read at https://www.dispatchtribunal.com/2017/10/28/ballentine-partners-llc-has-2-18-million-holdings-in-unitedhealth-group-incorporated-unh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.